Drug Shortage Report for HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML
Report ID | 148896 |
Drug Identification Number | 01935941 |
Brand name | HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML |
Common or Proper name | Heparin Sodium in 5% Dextrose Injection 25,000 USP Units / 500 mL |
Company Name | B. BRAUN MEDICAL INC |
Market Status | MARKETED |
Active Ingredient(s) | HEPARIN SODIUM CITRIC ACID SODIUM PHOSPHATE DIBASIC DEXTROSE |
Strength(s) | 5000UNIT 93MG 410MG 5G |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 500 mL |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | 2021-12-15 |
Actual start date | 2021-12-15 |
Estimated end date | 2022-02-28 |
Actual end date | 2022-02-08 |
Shortage status | Resolved |
Updated date | 2022-02-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 824 TWELFTH AVENUE BETHLEHEM, PENNSYLVANIA UNITED STATES 18018 |
Company contact information | Cindy Katsempris; cindy.katsempris@bbraunusa.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2022-02-09 | English | Compare |
v11 | 2022-02-08 | French | Compare |
v10 | 2022-02-08 | English | Compare |
v9 | 2022-01-21 | French | Compare |
v8 | 2022-01-21 | English | Compare |
v7 | 2021-12-16 | English | Compare |
v6 | 2021-12-10 | French | Compare |
v5 | 2021-12-10 | English | Compare |
v4 | 2021-11-10 | French | Compare |
v3 | 2021-11-10 | English | Compare |
v2 | 2021-11-05 | French | Compare |
v1 | 2021-11-05 | English | Compare |
Showing 1 to 12 of 12